Jiangsu Nhwa Pharmaceutical Co.,Ltd.(002262.SZ)
Profile
Registered Capital:
234.00(RMB MLN)
Employees:
1757
Email:
nhwadsb@nhwa-group.com

WebSite:
http://www.nhwa-group.com
Tel:
0516-87661012
Fax:
0516-87767118
Introduction from Google Finance
Jiangsu Nhwa Pharmaceutical Co., LTD is principally engaged in the manufacture of pharmaceutical preparations and medical raw materials. The Company is also involved in the wholesale and retail of pharmaceuticals through its subsidiaries. The Company offers its pharmaceutical products under five categories: anesthetic medicines, including midazolam injections, etomidate fat emulsion injections, and doxapram hydrochloride injections; psychiatric medicines, including risperidone tablets, buspirone hydrochloride tablets, zaleplon capsules, midazolam maleate tablets and lithium carbonate sustained-release tablets; neurological medicines, including gabapentin capsules, riluzole tablets, zaleplon capsules, midazolam maleate tablets, midazolam maleate tablets and triazolam tablets; other drugs, such as naproxen sustained-release capsules, as well as bulk drugs, such as fenofibrate and miconazole nitrate.
Reports
2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统